Showing results (981-990 of 1,322) with videos related to

Sort By:
Pageof 133
Drugs|December 19, 2018
Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future PerspectivesAura D Herrera-Martínez, Johannes Hofland, Leo J Hofland, et al.
The Journal of Clinical Endocrinology and Metabolism|July 24, 2008
Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomantS J C M M Neggers, M O van Aken, W W de Herder, et al.
Journal of Neuroendocrinology|April 14, 2026
The effect of LysaKare infusion on serum potassium levels in patients with gastroenteropancreatic neuroendocrine tumours eligible for treatment with [177Lu]Lu-DOTA-TATE: A post-authorisation safety studyJohannes Hofland, Chiara Maria Grana, Martin O Weickert, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 14, 2026
Dietary omega-3 polyunsaturated fatty acids relate to lower liver lipids and adipose-tissue insulin resistance, modulated by fatty acid desaturase 1 rs174546 in type 2 diabetesKeita Suzuki, Kálmán B Bódis, Kalliopi Pafili, et al.
Nutrition Journal|May 10, 2025
Cross-sectional association between the isocaloric replacement of carbohydrates with protein and fat in relation to fat compartments distribution and hepatic lipid content in recent-onset type 1 and type 2 diabetesAlexander Lang, Edyta Schaefer, Yuliya Kupriyanova, et al.
Diabetologia|December 6, 2022
Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathyHaifa Maalmi, Alexander Strom, Agnese Petrera, et al.
Plos One|March 29, 2016
Association between DNA Methylation in Whole Blood and Measures of Glucose Metabolism: KORA F4 StudyJennifer Kriebel, Christian Herder, Wolfgang Rathmann, et al.
Frontiers in Endocrinology|May 24, 2023
Epigenetic regulation of SST2 expression in small intestinal neuroendocrine tumorsMaria J Klomp, Julie Refardt, Peter M van Koetsveld, et al.
European Journal of Endocrinology|August 22, 2015
Biomarkers of iron metabolism are independently associated with impaired glucose metabolism and type 2 diabetes: the KORA F4 studyCornelia Huth, Simon Beuerle, Astrid Zierer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 1, 2022
Induction therapy with 177Lu-DOTATATE procures long-term survival in locally advanced or oligometastatic pancreatic neuroendocrine neoplasm patientsNoémie S Minczeles, Casper H J van Eijck, Marjon J van Gils, et al.
Pageof 133